INTRODUCTION
Nitrogen containing heterocycles constitute the major portion of chemical entities, which are part of many biologically active pharmaceuticals, fine chemicals, natural products and play a vital role in increasing the quality of life. 1 The compound 1, 2, 4-triazole and its derivatives were reported to show various pharmacological applications like antimicrobial, anticancer, antioxidant, anti-inflammatory and analgesic properties. [2] [3] [4] [5] They have other applications such as dyes, lubricants and analytical reagents. 6 Nowadays, drugs like alprazolam (anxiolytic agent), itraconazole (an antifungal agent), rizatriptan (antimigraine agent), fluconazole and ribavirin (antiviral agent) are the best examples of effective molecules with triazole nucleus. Further, the pyrazole derivatives also reported exhibiting diverse biological activities. [7] [8] [9] During the last few decades a significant number of new species with a wide range of biological activities (e.g. anticancer, antimicrobial etc.) and low cytotoxicity have been reported. This is due to the fact that pathogens frequently undergo mutations and exhibit the resistance to the particular antibiotics.
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from 3-substituted-4-amino-5-mercapto-1, 2, 4-triazoles exhibit remarkable anti-breast cancer, antiinflammatory, analgesic, antidepressant, antimicrobial activities 22, 23 and they are useful analytical reagents [24] [25] [26] [27] . In view of medicinal and biological properties of 3-substituted-4-amino-5-mercapto-1, 2, 4-triazoles, substituted pyrazoles; we thought that the combination of these moieties would result in enhanced biological activities. There is no report on condensation of 1, 3-diphenyl-1H-pyrazole-4-carbaldehyde with 4-amino-5-methyl-4H-1, 2, 4-triazole-3-thiols to form Schiff bases using methanol and acetic acid. In the present article, we report the synthesis of a series of biologically active Schiff bases achieved through condensation of 3-substituted-4-amino-5-mercapto-1, 2, 4-triazole with substituted 1, 3-diphenyl-1H-pyrazole-4-carbaldehydes. The synthesized Schiff bases were characterized by different spectral techniques. The modes of active binding sites for biological activities were studied by molecular docking.
EXPERIMENTAL Materials and Reagents
All the chemicals were purchased from a commercial supplier, Research Lab Chemicals, Mumbai. Substituted acetophenones (99 % pure, LR grade), methanol and DMF (Merck, 99 %) were used without further purification. Phenyl hydrazine and hydrazine hydrate (Sigma Aldrich, 98%) were used after distillation. Precoated silica aluminium plates of Merck were used for TLC.
Characterization
Melting points of synthesized compounds were taken by open tube capillary method and are uncorrected. The 1 H NMR spectra were recorded on a Bruker 400 MHz spectrophotometer using tetramethylsilane (TMS) as an internal standard. The IR spectra were recorded on Thermo Fisher IR instrument by ATR technique. The mass spectra were recorded on Thermo Scientific Q-Exactive, Accela 1250 pump. The completion of reaction and purity of the synthesized compounds were checked by TLC using a proper proportion of petroleum ether and ethyl acetate as solvent.
General Procedure for Synthesis of Schiff Bases (EP 1-EP 10)
1, 3-diphenyl-1H-pyrazole-4-carbaldehydes (1) were synthesized from 1-phenylethane-1-one using literature procedure 28 . 4-Amino-5-methyl-4H-1, 2, 4-triazole-3-thiol (2) was synthesized from hydrazine hydrate, carbon disulphide and acetic acid 29 . 1,3-diphenyl-1H-pyrazole-4-carbaldehyde (1 mmol) and 4-amino-5-methyl-4H-1, 2, 4-triazole-3-thiol (1 mmol) were condensed by refluxing them for 3-4 h in methanol (20 mL) in the presence of acetic acid (Scheme-1). The reaction was monitored by TLC (PE:EA-3:1). After completion of the reaction, the mixture was poured on crushed ice. The solid product separated out was recrystallized from ethanol. The physical data is represented in Table- 
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RESULTS AND DISCUSSION Chemistry
To optimize the most appropriate parameters such as solvent, amount of catalyst, reaction temperature and reaction time we have investigated the reaction of 3-(4-nitrophenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde (1) Table- 1. After optimization of reaction conditions, various aldehydes were used in this multi-component condensation reaction. Table-1 (entries 10 and 11) shows that condensation in methanol as a solvent in the presence of acetic acid or H2SO4as catalyst led to an excellent yield of the desired product. It was found that when the reaction is carried out in various solvents without catalyst the conversion of starting material into the product was not observed even after heating for 5-6 h (Table-1,entries 1and 2) indicating the need of a catalyst for the reaction. In presence of citric acid or sulphuric acid as a catalyst in water , the product was not obtained (Table-1 ,entries 3 and 6), but in the presence of citric acid as a catalyst in 50 % ethanol or 99.9 % ethanol gave trace amount of product (Table-1, entries 4 and 5). In the presence of sulphuric acid catalyst and 50% ethanol as a solvent, the reaction afforded a moderate yield of product (Table- 1, entry 7) . A good yield of the product was obtained when the reaction was performed in absolute ethanol in presence of sulphuric acid as a catalyst (Table-1, entry 8). Further, a good yield of product was obtained when the reaction was carried out in presence of acetic acid as a catalyst in absolute alcohol (Table-1, entry 9). In view of green practice, we had used acetic acid as less hazardous catalyst and methanol as a solvent. Synthesized compounds were characterized by spectral techniques such as 1 H NMR, 13 C NMR, IR, mass spectroscopy. Yields of the products range between 70 to 85 %. Physical constants and yields are recorded in Table- 
Pharmacology
The antibacterial evaluation of synthesized compounds revealed that some of the screened compounds exhibited excellent inhibition at 5µg/ml concentration. The antibacterial evaluation revealed that among the screened compounds, EP 2 and EP 8 exhibit excellent activities against all the tested bacterial strains like E.coli., Klebsiella spp., Proteus spp., Acinetobacter spp. and Enterobacter spp. (Fig.-1) .The remaining compounds show antibacterial activity at higher concentrations. All the results obtained are shown in Table- 3. The anti-inflammatory activity of synthesized compounds is shown in Fig.-2 .
Compound EP 10 showed excellent activity at 1 mM and compounds EP 3, EP 6, and EP 8 showed moderate activity. Anti-oxidant activity of synthesized compounds is shown in Fig.-3 , compound EP 5 exhibited excellent activity while EP 8 exhibited moderate activity at 1 mM.
Antibacterial Studies
The synthesized compounds were dissolved in DMSO, so as to ensure that the solvent had no effect on the bacterial growth or the enzymatic activity. Negative control tests were also performed using DMSO at the same concentrations. Five different bacteria Viz. E.coli., Klebsiella spp., Proteus spp., Acinetobacter spp. and Enterobacter spp.were evaluated using agar gel diffusion method. The inhibitory effect of all compounds on in-vitro growth of bacteria was evaluated using agar diffusion method (cup and plate method) 30 ,by measuring the zone of inhibition on agar plates at three different concentrations 1.25 µg/ml, 2.5µg/ml and 5.0 µg/ml. DMSO was used as a solvent control. All plates were incubated at 37± 0.5ºC for 24 hours. The zones of inhibition of compounds were measured using mm scale. Streptomycin was used as reference drug and treated similarly for determination of zone of inhibition and the results are shown in Table- 3. The graphical representation of the antibacterial activity of EP 2 against pathogenic bacteria is shown in Fig.-1 . 
In Vitro Anti-inflammatory Activity
The anti-inflammatory activity was measured by protein denaturation method. The reaction mixture (10 mL) consisted egg albumin (of 0.4 mL, from fresh hen egg), phosphate buffered saline (5.6 mL, PBS, pH 6.4) and synthetic derivatives (4 mL, 1 mM). A similar volume of double-distilled water was used as a control. Then the mixtures were incubated at (37 ºC ±2) in an incubator for 15 minutes and then heated at 70 ºC for 5 minutes. After cooling, the absorbance was measured at 660 nm. Diclofenac sodium (1 mM) was used as reference drug and processed similarly for determination of absorbance. The percentage inhibition of protein denaturation was calculated by using the formula, % Inhibition = 100 x Where, Vt = absorbance of the test sample. Vc = absorbance of control.
Antioxidant Activity
The molecule 1, 1-diphenyl-2-picrylhydrazyl (a,a-diphenyl-bipicrylhydrazyl; DPPH) is characterized as a stable free radical by virtue of the delocalization of the electron over the molecule as a whole so that the molecule does not dimerize, as would be the case with most other free radicals. The delocalization of electron also gives rise to the deep violet color, characterized by an absorption band in ethanol solution centered at about 517 nm. When a solution of DPPH is mixed with the substrate (AH), it donates a hydrogen atom, and gives rise to the reduced form with the loss of this violet color. The ability of synthesized compounds to scavenge DPPH radical was assessed using Kumar et al 31 and Manzocco et al 32 method with modification. Briefly, 1 ml of synthesized compound (1 mM) was mixed with DPPH (3.0 mL, 0.5 mmol/L in methanol), the resultant absorbance was recorded at 517 nm after 30 minutes incubation at 37 ºC. The percentage of scavenging activity was derived using the formula, % Inhibition = -x 100 Where, A control -absorbance of DPPH A sample -absorbance of the reaction mixture (DPPH with sample).
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Molecular Modeling
The virtual analysis was employed to determine the mode of action for the antimicrobial potential of synthesized triazole derivatives. and the addition of native hydrogen atoms. Structures of molecules understudy were drawn using 2D molecule builder and converted into the 3D structure using a 3D converter and optimized using molecular force field till gradient value of 0.001 kcal/(mol Å) is reached. Grip-based docking simulations were performed keeping protein structure rigid and ligand structure flexible. Binding modes of EP 5 and EP 10 are shown in Fig.-4 C NMR, IR and mass spectroscopic techniques. All the synthesized compounds were evaluated for their antibacterial, anti-inflammatory and anti oxidant activities and their zones of inhibition were determined. Antimicrobial activity study suggested that compound EP 2 and EP 8 having p-bromo and p-fluoro substitution respectively exhibited maximum inhibition against all the tested microorganisms. Similarly, compounds EP 4 and EP 10 having p-methoxy and m-nitro substituents also showed significant activity against microorganisms Citrobacter spp., E. coli, Klebsiella spp. All remaining compounds showed restrained inhibition. Compound EP 8 (71.55%) and EP 10 (74.31 %) exhibit excellent anti-inflammatory activity while compound EP 5 (56.87 %) and EP 8 (52.50 %) exhibit good antioxidant activity.1, 2, 4-triazole nucleus is one of the energetic components present in all molecules contributing to the net biological activity of the synthesized compounds.
